228 related articles for article (PubMed ID: 6090618)
1. The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agent.
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Sasaki Y; Imaoka S; Ishiguro S; Kasugai H; Okano Y; Tanaka S
J Nucl Med; 1984 Oct; 25(10):1122-6. PubMed ID: 6090618
[TBL] [Abstract][Full Text] [Related]
2. Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imaging.
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Noguchi A; Sasaki Y; Imaoka S; Fujita M; Kawamoto S; Kasugai H
Cancer; 1986 Jan; 57(2):230-6. PubMed ID: 2417674
[TBL] [Abstract][Full Text] [Related]
3. Relationship of uptake of technetium-99m(Sn)-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma to prognosis.
Hasegawa Y; Nakano S; Hiyama T; Sobue T; Yoshida H; Sasaki Y; Imaoka S; Inoue A; Tanaka S; Kusagai H
J Nucl Med; 1991 Feb; 32(2):228-35. PubMed ID: 1846910
[TBL] [Abstract][Full Text] [Related]
4. [Delayed Tc-99m-PMT imaging in the specific diagnosis of hepatocellular carcinoma].
Wu ZM
Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):360-3. PubMed ID: 2854779
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy of hepatobiliary scintigraphy using 99m Tc-N-pyridoxyl-5-methyltryptophan (PMT)].
Aburano T; Ohguchi M; Kuwajima A; Tonami N; Hisada K
Kaku Igaku; 1983 Apr; 20(3):353-60. PubMed ID: 6632363
[No Abstract] [Full Text] [Related]
6. Comparison of delayed hepatobiliary imaging using 99mTc-Sn-N-pyridoxyl-5-methyltryptophan and 67Ga-citrate imaging for diagnosis of hepatocellular carcinoma.
Hasegawa Y; Nakano S; Ishiguro S; Imaoka S; Sasaki Y; Tanaka S; Kasugai H; Kojima J; Ishigami S
Eur J Nucl Med; 1988; 14(7-8):414-8. PubMed ID: 2846309
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary scintigraphy and function test with 99mTc-N-pyridoxyl-5-methyltryptophan (99mTC-PMT).
Sugimura K; Nishiyama S; Narabayashi I
Kobe J Med Sci; 1985 Apr; 31(2):85-94. PubMed ID: 4021432
[No Abstract] [Full Text] [Related]
8. [Clinical evaluation of 99mTc-N-pyridoxyl-5-methyltryptophan hepatobiliary scintigraphy in hepatocellular carcinoma].
Kashiwagi T; Azuma M; Matsuda H; Yoshioka H; Ishizu H; Mitsutani N; Koizumi T; Kobayashi Y
Nihon Shokakibyo Gakkai Zasshi; 1985 Sep; 82(9):2061-7. PubMed ID: 2419606
[No Abstract] [Full Text] [Related]
9. Comparison of delayed imaging with Tc-99m PMT and Tc-99m DEIDA for visualization of hepatoma.
Hasegawa Y; Nakano S; Hashizume T; Noguchi A; Ibuka K; Kasugai H; Kojima J; Ishigami S
Clin Nucl Med; 1989 Jul; 14(7):526-31. PubMed ID: 2548797
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of 99mTc-PMT delayed imaging in diagnosis of hepatocellular carcinoma].
Hasegawa Y; Nakano S; Ibuka K; Hashizume T; Noguchi A; Kasugai H; Tanaka S; Inoue A; Kojima J; Fujita M
Kaku Igaku; 1992 Mar; 29(3):367-76. PubMed ID: 1316500
[TBL] [Abstract][Full Text] [Related]
11. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.
Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K
Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of 99mTc-(Sn)-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in diagnosis of hepatoma].
Hasegawa Y; Nakano S; Noguchi A; Hashizume T; Ibuka K; Sasaki Y; Imaoka M; Kozima J; Ishigami S
Kaku Igaku; 1983 Nov; 20(9):1355-9. PubMed ID: 6328071
[No Abstract] [Full Text] [Related]
13. [Clinical evaluation of the hepatobiliary scintigraphy using 99mTc-N-pyridoxyl-5-methyl tryptophan (99mTc-PMT)].
Kuwabara Y; Oshiumi Y; Ichiya Y; Wada M; Shiozaki H; Hirata N; Matsuura K
Radioisotopes; 1983 Jan; 32(1):26-9. PubMed ID: 6856881
[No Abstract] [Full Text] [Related]
14. A hepatobiliary study with Tc-99m N-pyridoxyl-5-methyltryptophan (PMT) in a patient with hepatoblastoma.
Ohshiro K; Hanashiro Y; Shimabukuro K; Hori A; Nagata Y; Matsumoto H; Uchima H
Clin Nucl Med; 1991 Jan; 16(1):10-2. PubMed ID: 1847848
[TBL] [Abstract][Full Text] [Related]
15. [Experimental and clinical studies of hepatobiliary scintigraphy using 99mTc-N-pyridoxyl-5-methyltryptophan(99mTc-PMT)].
Yoshida H; Kanamori I; Nakano S; Takeda I; Yasuda E; Matsuo S; Ichikawa H; Kimura T; Iwata F; Higuchi C
Radioisotopes; 1983 Jul; 32(7):340-43. PubMed ID: 6658021
[No Abstract] [Full Text] [Related]
16. [Diagnostic value of 99mTc-PMT delayed hepatobiliary imaging in small hepatocellular carcinoma--an analysis of 62 cases].
Chen SL
Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):30-2. PubMed ID: 1653687
[TBL] [Abstract][Full Text] [Related]
17. Concentration and clearance of Tc-99m-pyridoxylidene isoleucine by a hepatoma.
Ueno K; Haseda Y
Clin Nucl Med; 1980 May; 5(5):196-9. PubMed ID: 6245828
[TBL] [Abstract][Full Text] [Related]
18. [Scintigraphy using 99mTc-PMT, 99mTc-DEIDA, or 67Ga--detection of hepatocellular carcinoma and its metastasis].
Hasegawa Y; Nakano S
Nihon Rinsho; 1991 Aug; 49(8):1858-62. PubMed ID: 1664892
[No Abstract] [Full Text] [Related]
19. Hepatoma visualization with Tc-99m pyridoxylidene glutamate.
Utz JA; Lull RJ; Anderson JH; Lambrecht RW; Brown JM; Henry W
J Nucl Med; 1980 Aug; 21(8):747-9. PubMed ID: 6249896
[TBL] [Abstract][Full Text] [Related]
20. Analysis of factors affecting uptake of Tc-99m Sn-N-pyridoxyl-5-methyltryptophan by hepatocellular carcinoma.
Hasegawa Y; Nakano S; Sobue T; Fujita M; Ishiguro S; Sasaki Y; Imaoka S; Tanaka S; Kasugai H; Inoue A
Ann Nucl Med; 1994 May; 8(2):139-45. PubMed ID: 7521195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
